Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.33 USD | -0.65% | -2.97% | -14.73% |
Apr. 25 | Cigna to offer Humira rivals with $0 copay at specialty pharmacy | RE |
Apr. 25 | CVS Health Corporation Opens New Workforce Development and Community Resource Center in Baton Rouge | CI |
Evolution of the average Target Price on CVS Health Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering CVS Health Corporation
Leerink Partners | |
Truist Securities | |
Wells Fargo Securities | |
Piper Sandler | |
RBC Capital Markets | |
Deutsche Bank Securities | |
HSBC | |
TD Cowen | |
Bernstein | |
Evercore ISI | |
Wolfe Research | |
Edward Jones | |
DA Davidson | |
Raymond James | |
Morgan Stanley | |
UBS | |
Barclays | |
Jefferies & Co. | |
Mizuho Securities | |
JPMorgan Chase | |
Goldman Sachs | |
Cantor Fitzgerald | |
BofA Securities | |
Credit Suisse | |
Loop Capital | |
Tigress Financial | |
BMO Capital | |
Baird | |
Seaport Global Securities | |
Guggenheim |
EPS Revisions
- Stock Market
- Equities
- CVS Stock
- Consensus CVS Health Corporation